Lung Cancer Doctors Abroad — Page 3

Professor Ozcan Yildiz is a senior medical oncologist at Medipol Mega University Hospital with a focus on identifying rare presentations of small cell lung cancer.

• Specialises in system-wide drug therapies for both small cell and non-small cell lung cancers
• Published international research on managing thymoma and neuroendocrine tumours involving the chest
• Expert in identifying paraneoplastic syndromes, which are secondary conditions triggered by an immune response to lung cancer
• Focuses on multidisciplinary care for complex metastatic cases requiring systemic intervention

Professor of oncosurgery and proctology

Dr Saban Sec is a leading Turkish medical oncologist who specialises in targeted systemic therapies for lung cancer and complex sarcomas. He serves as a representative for the Turkish Medical Oncology Association, helping to shape clinical standards for specialist physicians.

• Focuses on non-small cell lung cancer (NSCLC) management using immune-based and chemotherapeutic protocols
• Conducted research on prognostic markers in lung cancer to help clinicians better predict patient survival
• Expertise includes managing rare tumours and gastrointestinal cancers within a multidisciplinary team
• Active member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association

Professor Turkan Ozturk Topcu is a medical oncology specialist at Valued Med Hub Hospitals who trained at the world-renowned MD Anderson Cancer Center in the USA.

• Specialises in managing lung cancer alongside trachea and bronchial malignancies
• Focuses on targeted protocols for mesothelioma and respiratory system tumours
• Completed international fellowships at Moffitt Cancer Center and Sunnybrook Odette Cancer Center
• Expert in medical oncology, including clinical management of thoracic oncology cases
• Experienced in treating complex cases across internal medicine and oncology clinics

Professor Gunluoglu is a senior thoracic surgeon at Medipol Mega University Hospital, where he provides specialised surgical reviews for complex respiratory cases.

• Specialises in thoracic surgery focusing on surgical interventions for the chest and lungs
• Provides expert second medical opinions for complex treatment planning
• Member of the Thoracic Surgery Department at a major university teaching hospital
• Collaborates with multidisciplinary oncology teams to refine patient care pathways

Professor Didem Tastekin is a leading medical oncologist at Valued Med Hub Hospitals, specialising in lung cancer and innovative therapies like cancer vaccines.

• Trained at the Istanbul University Oncology Institute, a premier centre for specialized cancer research
• Focuses on personalized treatment plans including immunotherapy and targeted drug delivery
• Held senior academic roles at Selçuk University and Atatürk University
• Expertise includes managing rare lung cancers and complex gastrointestinal cases
• Regarded for her work in medical oncology sub-specialist training across Turkey

The doctor is an oncologist specializing in the treatment of breast, lung, and gastrointestinal cancers. Currently, the doctor practices at Istinye Liv University Hospital.

With a career spanning multiple esteemed institutions, the doctor has served as an Internal Medicine Specialist at Malatya State Hospital, a physician at Ankara Oncology Clinic, and a member of the Oncology Department at Erzurum Regional Training and Research Hospital.

The doctor graduated from the Faculty of Medicine at Selcuk University and achieved the title of Associate Professor in 2016.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Professor Cemil Bilir trained at the Cleveland Clinic and Northeastern University in the US, focusing on pharmaceutical biotechnology to improve drug delivery.

• Specialises in medical oncology for advanced-stage lung cancer management
• Current Professor of Medicine at Sakarya University Faculty of Medicine
• Utilises targeted drug therapies based on his research in pharmaceutical biotechnology
• Maintains international standards as a member of ASCO and ESMO
• Holds a PhD in inorganic chemistry to better understand chemotherapy compositions

Associate Professor Nail Paksoy is a prominent medical oncologist at Medipol Bahçelievler University Hospital with European Board Certification (ESMO). He specialises in managing complex lung cancer cases through targeted therapies and immunotherapy.

• Led clinical trials for Lorlatinib, investigating its effectiveness against specific gene-mutated lung cancers
• Specialises in immunotherapy protocols using Atezolizumab for small cell lung cancer patients
• Expert in treating NSCLC with ALK and ROS1 mutations using targeted drug therapies
• Published research on drug resistance, focusing on why some lung cancers stop responding to treatment
• Member of the European Society for Medical Oncology (ESMO) board

Associate Professor Tarik Salman brings high-level expertise to lung cancer care, having completed observerships at the world-renowned Memorial Sloan Kettering Cancer Center.

• Specialises in comprehensive genomic profiling to create individual treatment plans
• Uses targeted therapies and immunotherapy to attack specific cancer cells
• Previously served as an academic visitor at the Moffitt Cancer Center in the USA
• Former Board Member of the Turkish Society of Medical Oncology
• Active member of the European Society of Medical Oncology since 2012

Professor Ercan Ozden is a specialist medical oncologist at VM Medical Park Pendik who trained at Istanbul University's prestigious Cerrahpaşa Faculty of Medicine.

• Specialises in medical oncology for managing lung cancer cases
• Subspecialised at Kocaeli University's Faculty of Medicine
• Focuses on systemic therapies to target and control tumour growth
• Member of the medical oncology unit at a major JCI-accredited hospital

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Associate Professor Mustafa Serkan Alemdar is a dual-certified specialist in internal medicine and medical oncology at Medical Park Antalya Hospital Complex.

• Specialises in medical oncology for managing advanced lung cancer cases
• Completed specialist oncology training at Akdeniz University Faculty of Medicine
• Focuses on systemic therapies including targeted treatments and immunotherapy
• Collaborates with multidisciplinary teams to coordinate personalised cancer care plans
• Published researcher active in the Turkish medical oncology community